Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10777 - 10784 of 12008 results
Google pays BIG to state Attorney Generals for Improper Consumer Tracking
November 22, 2013| Blog| Viewpoint
Treasury Department/IRS Issue Guidance Instructing Employers on How to Make Claims for FICA Refunds or Credits Post-Windsor
November 22, 2013| Advisory| Viewpoint
Treasury Department/IRS Issue Guidance Instructing Employers on How To Make Claims for FICA Refunds or Credits Post-Windsor
November 22, 2013| Blog| Viewpoint
Associational Discrimination Claims under Massachusetts Law Require More than Just Association
November 22, 2013| Blog| Viewpoint
Bill to Ban Pregnancy Discrimination Unanimously Passed by New Jersey Senate
November 22, 2013| Blog| Viewpoint
Want to reduce or suspend safe harbor 401(k) employer contributions mid-year? IRS final regulations provide a new way.
November 20, 2013| Blog| Viewpoint
Traps for the Unwary: The Impact of the False Claims Act on Start-Up and Venture-Stage Life Sciences Companies
November 19, 2013| Blog| Viewpoint
Career opportunity at a Mintz client!
November 19, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|